Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 108.88
-0.06 (-0.06%)
At close: Mar 5, 2026
NSE:GKSL Revenue
Gujarat Kidney And Super Speciality had revenue of 232.46M INR in the quarter ending December 31, 2025, with 149.01% growth. This brings the company's revenue in the last twelve months to 612.17M. In the fiscal year ending March 31, 2025, Gujarat Kidney And Super Speciality had annual revenue of 402.42M with 742.89% growth.
Revenue (ttm)
612.17M
Revenue Growth
+742.89%
P/S Ratio
13.93
Revenue / Employee
1.73M
Employees
338
Market Cap
8.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | 11.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Park Medi World | 15.73B |
| Kovai Medical Center and Hospital | 15.29B |
| KMC Speciality Hospitals (India) | 2.84B |
| Asarfi Hospital | 1.61B |
| Hannah Joseph Hospital | 795.41M |
| KRM Ayurveda | 765.53M |
| Nephro Care India | 761.59M |
| Shanmuga Hospital | 480.16M |